Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia

被引:6
|
作者
Li, Jingyu [1 ]
Cai, Ailu [1 ]
Yuan, Qian [1 ]
Ding, Hao [1 ]
Zhao, Dan [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang, Liaoning, Peoples R China
关键词
Fetal Doppler; Placental growth factor; Pre-eclampsia; Serum biomarkers; Soluble fms-like tyrosine kinase-1; Uterine artery Doppler; ANGIOGENIC FACTORS; DYSFUNCTION; PREDICTION; MANIFESTATIONS; BIOMARKERS; ULTRASOUND; PREGNANCY; DIAGNOSIS; SFLT-1; ONSET;
D O I
10.1002/ijgo.12796
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To compare serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentrations among women with pre-eclampsia and healthy control women and to evaluate the associations of serum PlGF and sFlt-1 with fetal and uterine artery Doppler indices in pre-eclampsia. Methods A prospective cross-sectional study of 33 women with pre-eclampsia and 33 normotensive pregnant women attending a university hospital in China between January and November 2014. Serum PlGF and sFlt-1 were assayed by enzyme linked immunosorbent assays. Doppler indices of the uterine artery, umbilical artery, fetal middle cerebral artery, and ductus venosus were measured. Results The pulsatility index of the uterine artery was negatively correlated with PlGF (r, -0.487; P=0.004) and positively correlated with sFlt-1 (r, 0.420; P=0.015). Gestational age at birth was positively correlated with PlGF (r, 0.601, P<0.001) and negatively correlated with sFlt-1 (r, -0.568; P=0.001). Birth weight was positively correlated with PlGF (r, 0.555; P=0.001) and negatively correlated with sFlt-1 (r, -0.552; P=0.001). Apgar score was negatively correlated with sFlt-1 (r, -0.427; P=0.017). Conclusion Lower PlGF and higher sFlt-1 levels in maternal serum were significantly associated with increased uterine arterial impedance in pre-eclampsia.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [21] Value of a Placental-Specific to Total Soluble fms-Like Tyrosine Kinase 1 Ratio in Women with Pre-eclampsia
    Rowson, S.
    Reddy, M.
    Guingand, D. D.
    Wallace, E.
    Palmer, K.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 : 72 - 72
  • [22] Stability of Placental Growth Factor, soluble fms-like tyrosine kinase 1 and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma
    Rowson, S.
    Reddy, M.
    Rolnik, D.
    Da Silva Costa, F.
    Palmer, K.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 : 8 - 9
  • [23] Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma
    Rowson, Saskia
    Reddy, Maya
    Rolnik, Daniel L.
    Costa, Fabricio Da Silva
    Palmer, Kirsten R.
    PLACENTA, 2019, 86 : 1 - 3
  • [24] Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy
    Selvarajan, Sathya
    Ramalingam, Jothimalar
    Vijayaraghavan, Jaya
    Bobby, Zachariah
    JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (04) : 335 - 339
  • [25] Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia
    Boulanger, H.
    Drouin, D.
    Largilliere, C.
    Lefevre, G.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (08) : 695 - 697
  • [26] Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin
    Navaratnam, Kate
    Abreu, Patricia
    Clarke, Helen
    Jorgensen, Andrea
    Alfirevic, Ana
    Alfirevic, Zarko
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (02): : 179 - 187
  • [27] Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction
    Savvidou, Makrina D.
    Yu, Christina K.
    Harland, Lisa C.
    Hingorani, Aroon D.
    Nicolaides, Kypros H.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : 1668 - 1673
  • [28] Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
    Hastie, Roxanne
    Bergman, Lina
    Walker, Susan P.
    Kaitu'u-Lino, Tu'uhevaha
    Hannan, Natalie J.
    Brownfoot, Fiona
    Schell, Sonja
    Harper, Alesia
    Cannon, Ping
    Cluver, Catherine A.
    Tong, Stephen
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (16):
  • [29] Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase-1 and Placental Growth Factor in HIV-infected Preeclampsia
    Mlambo, Zinhle P. P.
    Khaliq, Olive P. P.
    Moodley, Jagidesa
    Naicker, Thajasvarie
    CURRENT HYPERTENSION REVIEWS, 2023, 19 (01) : 27 - 33
  • [30] First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy
    Schneuer, Francisco J.
    Nassar, Natasha
    Guilbert, Cyrille
    Tasevski, Vitomir
    Ashton, Anthony W.
    Morris, Jonathan M.
    Roberts, Christine L.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (04) : 215 - 221